| Cat. No. |
Product Name |
Information |
| PC-26955 |
UCM-1336
ICMT inhibitor
|
UCM-1336 is a potent, selective isoprenylcysteine carboxylmethyltransferase (ICMT) inhibitor with IC50 of 2 uM. |
| PC-26941 |
NCGC00138783 TFA
CD47/SIRPα inhibitor
|
NCGC00138783 TFA is a selective inhibitor targeting CD47/SIRPα axis with IC50 of 50 µM, directly blocks the interaction between CD47 and SIRPα. |
| PC-26940 |
NCGC00138783
CD47/SIRPα inhibitor
|
NCGC00138783 is a selective inhibitor targeting CD47/SIRPα axis with IC50 of 50 µM, directly blocks the interaction between CD47 and SIRPα. |
| PC-26939 |
NCGC00092410
GCase inhibitor
|
NCGC00092410 is a potent, selective and nonsugar glucocerebrosidase (GC, GCase) inhibitor with IC50 of 31 nM. |
| PC-26933 |
β-actin inhibitor C25
β-actin inhibitor
|
β-actin inhibitor C25 is potent, selective and covalent inhibitor of beta-actin (β-actin), does not target α- or γ-actin, inhibits β-Actin polymerization to disrupt the actin cytoskeleton and lead to cell death in143B cells (IC50=15 nM), selectively and covalently binds to Cys272 in β-actin. |
| PC-26921 |
GPR52 agonist 1
GPR52 agonist
|
GPR52 agonist 1 is a potent, BBB- penetrant and orally available agonist of orphan G-protein-coupled receptor 52 (GPR52) with pEC50 of 7.53, suppresses methamphetamine-induced hyperactivity in vivo. |
| PC-26920 |
B0045
VprBP inhibitor
|
B0045 is a specific, second-generation inhibitor of DCAF1 (Vpr-binding protein, VprBP), blocks VprBP-mediated H2AT120p and reactivates growth regulatory genes, resulting in a significantly lower proliferative capacity of prostate cancer cells. |
| PC-26911 |
IRG1-IN-1
IRG1 inhibitor
|
IRG1-IN-1 is an itaconic acid derivative and inhibitor of immune-responsive gene 1 (IRG1) activity. |
| PC-26910 |
CVM-05-002
PI5P4K inhibitor
|
CVM-05-002 is a potent and selective inhibitor of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) with IC50 of 0.27 uM and 1.69 uM for PI5P4Kα and PI5P4Kβ。 |
| PC-26909 |
066ATZ
PIP4K2A/2B inhibitor
|
066ATZ is a potent, selective dual PIP4K2A and PIP4K2B inhibitor with Ki of 100 nM and 800 nM. |
| PC-26907 |
Fexlamose
Mucolytic
|
Fexlamose (AER-01, MUC-031) is a potent and fast-acting mucolytic compound, cleaves disulfides to cause mucolysis, shows potential for muco-obstructive lung diseases like COPD (Chronic Obstructive Pulmonary Disease) and asthma. |
| PC-26904 |
ADGRL1 inhibitor compound 2
ADGRL1 inhibitor
|
ADGRL1 inhibitor compound 2 is a potential small molecule inhibitor of adhesion G protein-coupled receptor L1 (ADGRL1/Latrophilin-1), activates the GSK3β-STAT1 axis in CT26 cells in vitro, consistent with the knockdown of Adgrl1. |
